Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to -$1.6 million.

  • Medical Group Holdings' Change in Accured Expenses rose 6521.24% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year decrease of 4789.05%. This contributed to the annual value of -$12.1 million for FY2024, which is 37171.53% down from last year.
  • Per Medical Group Holdings' latest filing, its Change in Accured Expenses stood at -$1.6 million for Q3 2025, which was up 6521.24% from -$2.4 million recorded in Q2 2025.
  • In the past 5 years, Medical Group Holdings' Change in Accured Expenses registered a high of $4.2 million during Q4 2023, and its lowest value of -$4.6 million during Q3 2024.
  • Over the past 3 years, Medical Group Holdings' median Change in Accured Expenses value was -$1.6 million (recorded in 2025), while the average stood at -$1.1 million.
  • In the last 5 years, Medical Group Holdings' Change in Accured Expenses crashed by 2209257.3% in 2024 and then surged by 9389.23% in 2025.
  • Medical Group Holdings' Change in Accured Expenses (Quarter) stood at $4.2 million in 2023, then tumbled by 174.32% to -$3.1 million in 2024, then soared by 48.54% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$2.4 million for Q2 2025, and -$98005.0 during Q1 2025.